Skip to main content
SpringerLink
Log in

T cell killing of human colon carcinomas by monoclonal-antibody-targeted superantigens

  • Original articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Abstract

The bacterial superantigen staphylococcal enterotoxin A (SEA) induces T cell activation as well as directing activated T cells to kill major-histocompatibilitycomplex-class-II-expressing tumours such as freshly prepared leukemia cells. We now report that conjugates of SEA and the colon-carcinoma-reactive mAb C215 mediate T-cell-dependent killing of freshly isolated cells obtained from surgical specimens of human colon carcinomas. Cytotoxicity was observed at nanomolar concentrations of conjugate while no or very low effects were seen with the mAb C215 or SEA alone. Tumour-infiltrating lymphocytes (TIL) did not exert any cytotoxicity against conjugate-treated tumour cells immediately after isolation. In vitro culture of TIL with interleukin-2 and SEA resulted in SEA-mAb-conjugate-dependent killing of freshly isolated tumour cells. This suggests that mAb-SEA conjugates may be of potential use to target T lymphocytes, including TIL, against colon carcinoma cells in vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Alexander J, Rayman P, Edinger M, Conelly R, Tubbs R, Bukowsky R, Pontes E, Finke J (1990) TIL from renal-cell carcinoma: restimulation with tumour influences proliferation and cytolytic activity. Int J Cancer 45: 119

    Google Scholar 

  2. Andersson U, Adolf G, Dohlsten M, Möller G, Sjögren H-O (1989) Characterization of individual tumor necrosis factor alpha- and betaproducing cells after polyclonal T cell activation. J Immunol Methods 123: 233

    Google Scholar 

  3. Balch CM, Riley LB, Bae YJ, Salmeron MA, Platsoucas CD, von Eschenbach A, Itoh K (1990) Patterns of human tumor-infiltrating lympho-cytes in 120 human cancers. Arch Surg 125: 200

    Google Scholar 

  4. Björk P, Jönsson U, Sundblad G (1990) Characterization and purification of a membrane-associated glycoprotein in the human adenoma carcinoma cell line, Colo-205, defined by a mouse monoclonal antibody. J Cell Biochem [Suppl] 14D, 30

    Google Scholar 

  5. Carlsson R, Sjögren H-O (1985) Kinetics of IL-2 and interferongamma production, expression of IL-2 receptors, and cell proliferation in human mononuclear cells exposed to staphylococcal enterotoxin A. Cell Immunol 96: 175

    Google Scholar 

  6. Dohlsten M, Lando PA, Hedlund G, Trowsdale J, Kalland T (1990) Targeting of human cytotoxic T lymphocytes to MHC class II expressing cells by staphylococcal enterotoxins. Immunology 71: 96

    Google Scholar 

  7. Dohlsten M, Hedlund G, Segrén S, Lando PA, Herrmann T, Kelly AP, Kalland T (1991) Human major histocompatibility complex class II-negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptor. Eur J Immunol 21: 1229

    Google Scholar 

  8. Dohlsten M, Hedlund G, Lando PA, Trowsdale J, Altmann D, Patarroyo M, Fischer H, Kalland T (1991) Role of the adhesion molecule ICAM-1 (CD45) in staphylococcal enterotoxin-mediated cytotoxicity. Eur J Immunol 121: 131

    Google Scholar 

  9. Dohlsten M, Hedlund G, Åkerblom E, Lando PA, Kalland T (1991) Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents. Proc Natl Acad Sci USA 88: 9287

    Google Scholar 

  10. Ebert EC, Brolin RE, Roberts AI (1989) Characterization of activated lymphocytes in colon cancer. Clinical Immunol Immunopathol 50: 72

    Google Scholar 

  11. Fischer H, Dohlsten M, Lindvall M, Sjögren H-O, Carlsson R (1989). Binding of staphylococcal enterotoxin A to HLA-DR on B cell lines. J Immunol 142: 3151

    Google Scholar 

  12. Hedlund G, Dohlsten M, Lando P, Kalland T (1990) Staphylococcal enterotoxins direct and trigger CTL-killing of autologous HLA-DR+mononuclear leukocytes and freshly prepared leukemia cells. Cell Immunol 129: 426

    Google Scholar 

  13. Hedlund G, Dohlsten M, Herrmann T, Buell G, Lando PA, Segrén S, Schrimsher J, Macdonald HR, Sjögren H-O, Kalland T (1991) A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cells. J Immunol 147: 4082

    Google Scholar 

  14. Jamieson C, McCaffrey PG, Rao A, Sen R (1991) Physiological activation of T cells via the T cell receptor induces NF-κB. J Immunol 147: 416

    Google Scholar 

  15. Kalland T, Hedlund G, Dohlsten M, Lando PA (1991) Staphylococcal enterotoxin-dependent cell-mediated cytotoxicity. In: Fleischer B, Sjögren H-O (eds) Curr Top Microbiol Immunol 174: 81

    Google Scholar 

  16. Lando A, Dohlsten M, Kalland T, Sjögren HO, Carlsson R (1990) The TCR-CD3 complex is required for activation of human lymphocytes with staphylococcal enterotoxin A. Scand J Immunol 31: 133

    Google Scholar 

  17. Lando PA, Hedlund G, Dohlsten M, Kalland T (1991) Bacterial superantigens as anti-tumor agents: induction of tumor cytotoxicity in human lymphocytes by staphylococcal enterotoxin A. Cancer Immunol Immunother 33: 231

    Google Scholar 

  18. Larsson LN, Johansson C, Lindholm L, Holmgren J (1988) Mouse monoclonal antibodies for experimental immunotherapy promotes killing of tumor cells. Int J Cancer 42: 877

    Google Scholar 

  19. Marrack P, Kappler J (1990) The staphylococcal enterotoxins and their relatives. Science 248: 705

    Google Scholar 

  20. McDougall CJ, Ngoi SS, Goldman IS, Godwin T, Felix J, DeCosse JJ, Rigas B (1990) Reduced expression of HLA class I and II antigens in colon cancer. Cancer Res 50: 8023

    Google Scholar 

  21. Möller P, Momburg F, Koretz K, Moldenhauer G, Herfarth C, Otto HF, Hämmerling GJ, Schlag P (1991) Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma. Cancer Res 51: 729

    Google Scholar 

  22. Möller P, Koretz K, Schlag P, Momburg F (1991) Frequency of abnormal expression of HLA-A, B, C and HLA-DR molecules, invariant chain, and LFA-3 (CD58) in colorectal carcinoma and its impact on tumor recurrence. Int J Cancer [Suppl] 6: 155

    Google Scholar 

  23. Newell KA, Ellenhorn JDI, Bruce DS, Bleustone JA (1991) In vivo T-cell activation by staphylococcal enterotoxin B prevents outgrowth of malignant tumor. Proc Natl Acad Sci USA 88: 1074

    Google Scholar 

  24. Norazmi M, Hohmann AW, Skinner JM, Bradley J (1989) Expression of MHC class II, interleukin 2 receptor and CD45 antigens on tumor-associated T lymphocytes in colonic carcinoma. Br J Cancer 60: 685

    Google Scholar 

  25. Norazmi M, Hohmann AW, Skinner JM, Bradley J (1989) Expression of MHC class I and II antigens in colonic carcinomas. Pathology 21: 248

    Google Scholar 

  26. Riggs Jr CE, Bennett JP (1991) Clinical pharmacology of individual antineoplastic agents. In: Moossa AR, Schimpff SC, Robson MC (eds) Comprehensive textbook of oncology. Williams and Wilkins, Baltimore, p 537

    Google Scholar 

  27. Rosenberg SA, Packard BS, Aebersold PM, Solomon D, Topalian SL, Toy ST, Simon P, Lotze MT, Yang JC, Seipp CA, Simpson C, Carter C, Bock S, Schwartentrauber D, Wei P, White DE (1988) Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. N Engl J Med 319: 1676

    Google Scholar 

  28. Roulston A, D'Addario M, Bouleic F, Caplan S, Wainberg MA, and Hiscott J (1992) Induction of monocytic differentiation and NF-κB-like activities by human immunodeficiency virus 1 infection of myelomonoblastic cells. J Exp Med 175: 751

    Google Scholar 

  29. Staren ED, Economou SG, Harris JE, Braun DP (1989) Lymphokine-activated killer cell induction in tumor-infiltrating leukocytes from colon cancer patients. Cancer 64: 2238

    Google Scholar 

  30. Trudel JL, Youngman KR, West GA, Fazio VW, Fiocchi C (1988) Lymphokine-activated killler (LAK) cells from human intestinal mucosa: cytotoxic activity against tumor cell lines and modified self but not autologous and allogeneic colon cancer cells. J Surg Res 44: 445

    Google Scholar 

  31. Vose B (1982) Quantitation of proliferative and cytotoxic precursor cells directed against human tumors: limiting dilution analysis in peripheral blood and at the tumor site. Int J Cancer 30: 135

    Google Scholar 

  32. Whiteside T, Miescher S, MacDonald HR, Von Fleidner V (1986) Separation of tumor-infiltrating lymphocytes from tumor cells in human solid tumors: a comparison between velocity sedimentation and discontinuous density gradients. J Immunol Methods 90: 221

    Google Scholar 

  33. Wölfel T, Klehmann E, Muller C, Schutt KH, Meyer zum Buschenfelde KH, Knuth A (1989) Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens. J Exp Med 170: 797

    Google Scholar 

  34. Yoo YK, Heo DS, Hata K, Van Thiel DH, Whiteside T (1990) Tumor-infiltrating lymphocytes from human colon carcinomas: functional and phenotypic characteristics after long-term culture in rcombinant interleukin 2. Gastroenterology 98: 259

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kabi Pharmacia Therapeutics, Scheelevägen 22, S-223 63, Lund, Sweden

    Peter A. Lando, Mikael Dohlsten, Gunnar Hedlund, Eva Åkerblom & Terje Kalland

  2. The Department of Tumour Immunology, the Wallenberg Laboratory, University of Lund, Box 7031, S-220 07, Lund, Sweden

    Mikael Dohlsten, Gunnar Hedlund & Terje Kalland

Authors
  1. Peter A. Lando
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mikael Dohlsten
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gunnar Hedlund
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eva Åkerblom
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Terje Kalland
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lando, P.A., Dohlsten, M., Hedlund, G. et al. T cell killing of human colon carcinomas by monoclonal-antibody-targeted superantigens. Cancer Immunol Immunother 36, 223–228 (1993). https://doi.org/10.1007/BF01740903

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01740903

Key words

Search

Navigation